Trial NCT03832673

View at ClinicalTrials.gov 
Org. Study IDs: NT

Last trial update was posted on 2021-02-26

MeSH Interventions

Pembrolizumab

MeSH Conditions

Urinary Bladder Neoplasms

Other Conditions

Muscle-invasive Bladder Cancer

Stopping Reasons

Regolatory National Agency (AIFA) not approved

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID